Incentive-Eligible Drugs for Substitution Dispensary Reach 2,357

Published: 2005-03-22 06:59:00

Updated: 2005-03-22 06:59:00

According to the latest report released by the Health Insurance Review Agency (HIRA) on the list of incentive-eligible drugs for substitution dispensary, the total number has reached at 2,357 items as of February.

Out of 2,666 items that has been tested and approved for bioequivalence, 2,357 ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK